Artificial Intelligence is rapidly transforming drug discovery, clinical research, and Alzheimer’s disease development, and IGC Pharma, Inc. (NYSE: IGC) is positioning itself at the forefront of that evolution. The clinical-stage…
Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) continues to accelerate commercialization after reporting record June 2026 sales orders, completing its Generation 2.0 Graphene Manufacturing Plant, and approving the next…
Investors following the rapidly growing Alzheimer’s disease, Artificial Intelligence (AI), and biotechnology sectors now have an opportunity to hear directly from IGC Pharma, Inc. (NYSE American: IGC) CEO Ram Mukunda…
The rapid expansion of Artificial Intelligence (AI) is driving unprecedented demand for AI Data Centers, GPU Infrastructure, High-Performance Computing (HPC), Cloud Computing, and reliable power infrastructure. As demand for AI…
As the global drone, AI infrastructure, and autonomous systems markets accelerate, the industry’s next major challenge is shifting from keeping drones in the air to keeping them securely connected. While…
Related posts: No related posts here.
Investors searching for high-upside opportunities continue watching nanocap companies operating in fast-growing industries such as sustainable agriculture, critical minerals, fusion energy, biotechnology, and entertainment. While these stocks carry higher risk,…
The global race to build Artificial Intelligence (AI) infrastructure is rapidly reshaping the digital economy, with AI Data Centers, High-Performance Computing (HPC), GPU Infrastructure, Cloud Computing, and reliable power generation…
As investors continue searching for opportunities in artificial intelligence, defense technology, critical minerals, energy infrastructure, uranium, gold, and advanced materials, several North American companies are attracting attention through strategic developments…
IGC Pharma, Inc. (NYSE: IGC), a clinical-stage biotechnology company developing Alzheimer’s disease therapeutics and AI-enabled healthcare technologies, disclosed in a Form 4 filing that two senior executives increased their ownership…
